gifttaste.blogg.se - Medication look up by description

#Medication look up by description software

The Commission expects that it will be widely adopted into electronic health initiatives and standards. Implementing Tall Man lettering in Australia is encouraged by some, but the lack of standards for its application has been a significant barrier. Provide credibility to the technique as a tool, which can be used to help reduce the risks associated with look-alike, sound-alike (LASA) medicine name pairs.Ensure that the best available scientific evidence is used to support the development of Tall Man names.

#Medication look up by description software

Prevent the proliferation of various lists of Tall Man names, which may lead to inconsistency in the application of the technique and result in confusion among clinicians, software vendors, regulators and the pharmaceutical industry.helping clinicians select the right product in electronic systems or from shelves.warning clinicians about the risk of confusing medicine names.The List compiles LASA medicine name pairs (generic and brand name pairs) that have been predicted to pose the greatest risks to patient safety. It uses a combination of lower- and upper-case letters to highlight the differences between look-alike medicine names, helping to make them more easily distinguishable. Automated medicines storage and distribution systems.Printed labels used for inpatient dispensing, shelving in pharmacies, and ward medicines cupboards.Electronic medication management systems, including prescribing, dispensing and administration systems.Tall Man lettering should be used by clinicians and health service organisations in: The Commission supports the use of Tall Man lettering as part of a multi-faceted approach to reduce the risk of selection errors by health professionals associated with LASA medicines names.

Removal of a discontinued medicine (and its pair) from the general list of medicine name pairs.

Addition of cloBAZam to the benzodiazepine class of medicines.

In 2020, revisions were made to the List, including: The List reflects the changes to the Australian Register of Therapeutic Goods, international Tall Man lettering lists, International Harmonisation of Ingredient Names and reported adverse incidents or near misses from hospital networks across Australia. The Commission has revised the National Tall Man Lettering List, initially published in 2011. The Commission is responsible for the development and stewardship of the National Tall Man Lettering List (the List). The medicines names have Tall Man lettering applied to them consistent with the national convention and should be used in the form provided. The List shows LASA medicine names in pairs or groups.